Emd Serono Research & Development Institute, Inc.
Clinical trials sponsored by Emd Serono Research & Development Institute, Inc., explained in plain language.
-
New pill shows promise for lupus in Mid-Stage trial
Disease control CompletedThis study tested an experimental pill called enpatoran in 456 adults with lupus (SLE) or lupus affecting the skin (CLE). Participants took the drug or a placebo for 24 weeks while continuing their usual treatments. The goal was to see if enpatoran safely reduces skin rashes and …
Phase: PHASE2 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New cancer drug combo tested in early trial – no cure yet
Disease control CompletedThis early-phase study tested a new drug called M6223, alone or with another drug (bintrafusp alfa), in 58 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and find the best dose. The study is complete, but re…
Phase: PHASE1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New hope for MS patients: cladribine tablets studied after other drugs fail
Disease control CompletedThis study looked at how well cladribine tablets work for people with relapsing forms of multiple sclerosis (MS) who had a poor response to other oral or infusion treatments. Researchers tracked the number of relapses and how satisfied patients were with the medication over two y…
Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated May 06, 2026 16:13 UTC
-
Cancer drug Follow-Up study tracks Long-Term safety and survival
Disease control CompletedThis study followed 22 adults with lung cancer or other cancers who were already taking the drug bintrafusp alfa in earlier trials. The goal was to keep giving them the drug and watch for side effects and how long they lived. It is not a cure, but a way to manage the disease over…
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated May 05, 2026 11:56 UTC
-
Healthy men test two versions of fertility drug in bioequivalence study
Knowledge-focused CompletedThis study tested whether a new liquid form of follitropin alfa (a hormone used for fertility) works the same as the standard powder form. Fifty-five healthy men received both versions in a random order. The goal was to see if the levels of the drug in the blood were similar, not…
Phase: PHASE1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Knowledge-focused
Last updated May 11, 2026 20:50 UTC